WSJ News Exclusive | Horizon Therapeutics Fields Takeover Interest From Pharma Giants
The drugmaker recently had a market value almost $18 billion as big pharmaceutical companies rely on acquisitions to expand sales.
The drugmaker recently had a market value almost $18 billion as big pharmaceutical companies rely on acquisitions to expand sales.
MarketsFinancial RegulationProsecutors and regulators say healthcare company executive tipped friend to company’s drug approval
The crypto exchange is expected to walk away from deal to buy a collapsing competitor following a review of its ...
MarketsCurrenciesCryptocurrencyExchange says FTX was facing liquidity crunch; deal terms weren’t disclosed
Supermarket giant Albertsons’ planned $4 billion special dividend has stoked anger over its proposed combination with Kroger—but isn’t nearly as ...
WSJ News ExclusiveDealsThe VillageMD-Summit Health agreement could be finalized by Monday
By Ryan Dezember | Photographs by Amanda Andrade-Rhoades for The Wall Street Journal
The industrial company plans to sell a 55% stake in its climate-technologies business to the investment firm, in a deal ...
Michael Klein, matchmaker to powerful companies and investors, will now begin a third act—as a major Wall Street CEO at ...
The gay-dating platform will probably get the slow fade from investors in this market.